S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:STOR

STORE Capital (STOR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$32.21
$32.21
50-Day Range
$32.03
$32.21
52-Week Range
$24.48
$32.36
Volume
N/A
Average Volume
2.95 million shs
Market Capitalization
$9.11 billion
P/E Ratio
27.77
Dividend Yield
5.09%
Price Target
N/A

STORE Capital MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.59
Upright™ Environmental Score
News Sentiment
0.29mentions of STORE Capital in the last 14 days
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
0.90%
From $2.23 to $2.25 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.17 out of 5 stars

Finance Sector

755th out of 844 stocks

Real Estate Investment Trusts Industry

157th out of 179 stocks

STOR stock logo

About STORE Capital Stock (NYSE:STOR)

STORE Capital Corp. operates as an internally managed net-lease real estate investment trust. The firm engages in the acquisition, investment, management, and ownership of single tenant operational real estate properties. The company was founded by Mary Fedewa, Morton H. Fleischer, Christopher H. Volk, Catherine Long, Michael J. Zieg, and Michael T. Bennett on May 17, 2011, and is headquartered in Scottsdale, AZ.

STOR Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Samson Rock Capital LLP - Form 8.3 - Lok'n Store Group Plc
See More Headlines
Receive STOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STORE Capital and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/04/2022
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
N/A
Employees
117
Year Founded
N/A

Profitability

Net Income
$268.35 million
Pretax Margin
36.36%

Debt

Sales & Book Value

Annual Sales
$885.68 million
Cash Flow
$2.11 per share
Book Value
$18.86 per share

Miscellaneous

Free Float
280,114,000
Market Cap
$9.11 billion
Optionable
Optionable
Beta
0.93
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mary B. Fedewa
    President, Chief Executive Officer & Director
  • Chad Allen Freed
    Secretary, Executive VP & General Counsel
  • Ashley A. Dembowski
    Chief Accounting Officer & Senior Vice President
  • Craig A. Barnett
    EVP-Underwriting & Portfolio Management
  • Tyler S. Maertz
    Executive Vice President-Acquisitions

STOR Stock Analysis - Frequently Asked Questions

How were STORE Capital's earnings last quarter?

STORE Capital Co. (NYSE:STOR) announced its quarterly earnings results on Wednesday, May, 4th. The real estate investment trust reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.06. The real estate investment trust earned $222.12 million during the quarter, compared to the consensus estimate of $212.11 million. STORE Capital had a trailing twelve-month return on equity of 6.12% and a net margin of 36.26%. The firm's quarterly revenue was up 21.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.47 EPS.

Is STORE Capital a good dividend stock?

STORE Capital (NYSE:STOR) pays an annual dividend of $1.64 per share and currently has a dividend yield of 5.09%. STOR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 141.38%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, STOR will have a dividend payout ratio of 72.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STOR.

What other stocks do shareholders of STORE Capital own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STORE Capital investors own include AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Pfizer (PFE), Intel (INTC), Simon Property Group (SPG), Bank of America (BAC) and CVS Health (CVS).

When did STORE Capital IPO?

STORE Capital (STOR) raised $495 million in an initial public offering on Tuesday, November 18th 2014. The company issued 27,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, Credit Suisse and Morgan Stanley acted as the underwriters for the IPO and Citigroup, Deutsche Bank Securities, KeyBanc Capital Markets, Wells Fargo Securities, Baird, BMO Capital Markets, Comerica Securities, Raymond James, Stifel and SunTrust Robinson Humphrey were co-managers.

This page (NYSE:STOR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners